• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[经淋巴管造影检测的膈下淋巴系统内淋巴放射性核素治疗(ELRT)引起的长期变化]

[Lymphographically detectable long-term changes caused by endolymphatic radionuclide therapy (ELRT) in the infradiaphragmatic lymph system].

作者信息

Müller R P, Peters P E

出版信息

Strahlentherapie. 1985 Apr;161(4):239-43.

PMID:2986321
Abstract

In sixteen patients who had been treated 42 months before on an average for malignant melanomas of the lower extremity (stage I) by a unilateral endolymphatic therapy with 32P/131J-Lipiodol UF, bipedal lymphography with oily contrast medium was performed. In consequence of the high-dosed intralymphatic radiotherapy the lymph nodes of the treated side are markedly reduced in size and number; fourteen out of the sixteen patients, however, showed lymph nodes of normal size and structure which had not been coloured during ELRT. On the basis of this phenomenon, a possible mechanism of formation of metastases in previously treated lymph nodes is discussed. The presentation and extent of radiogenic reactions in the lymph vessels correspond to the changes known for percutaneous irradiation.

摘要

16例患者平均在42个月前曾接受过单侧内淋巴放射治疗(使用32P/131I -超液态碘化油),以治疗下肢恶性黑色素瘤(I期)。之后对这些患者进行了使用油性造影剂的双足淋巴造影。由于高剂量的淋巴管内放射治疗,治疗侧的淋巴结在大小和数量上明显减少;然而,16例患者中有14例显示出大小和结构正常的淋巴结,这些淋巴结在内淋巴放射治疗期间未被染色。基于这一现象,讨论了先前治疗过的淋巴结中转移灶形成的可能机制。淋巴管中放射反应的表现和程度与经皮照射已知的变化相符。

相似文献

1
[Lymphographically detectable long-term changes caused by endolymphatic radionuclide therapy (ELRT) in the infradiaphragmatic lymph system].[经淋巴管造影检测的膈下淋巴系统内淋巴放射性核素治疗(ELRT)引起的长期变化]
Strahlentherapie. 1985 Apr;161(4):239-43.
2
[Radiation dose to the lung following endolymphatic radionuclide therapy of melanoma of the lower limbs].
Strahlentherapie. 1985 Jan;161(1):23-9.
3
[Endolymphatic radionuclide therapy of the malignant melanoma (author's transl)].恶性黑色素瘤的内淋巴放射性核素治疗(作者译)
Strahlentherapie. 1978 Mar;154(3):169-73.
4
[Reliability of the diagnostic results obtained with confined quantities of the contrast medium in endolymphatic radionuclide therapy (ELRT) of the inferior limbs (author's transl)].[下肢内淋巴放射性核素治疗(ELRT)中使用限量造影剂获得的诊断结果的可靠性(作者译)]
Strahlentherapie. 1980 Aug;156(8):538-41.
5
[Endolymphatic lipiodol-P32 therapy in melanoma of the limbs during clinical stage 1].
Med Welt. 1974 Jun 7;25(23):1054-5.
6
[Indication establishment and dosimetry in endolymphatic therapy with I-131 lipiodol].[I-131 碘油内淋巴治疗的适应症确立与剂量测定]
Strahlentherapie. 1967 Aug;133(4):481-98.
7
Distribution pattern of radioactive labelled lipiodol-UF following intralymphatic application for therapy.放射性标记的超液态碘化油经淋巴管内注射用于治疗后的分布模式。
Lymphology. 1976 Sep;9(3):122-6.
8
Endolymphatic radiotherapy in malignant lymphomas. A clinical evaluation of 285 patients.恶性淋巴瘤的内淋巴放疗。285例患者的临床评估。
Cancer. 1968 Oct;22(4):885-98. doi: 10.1002/1097-0142(196810)22:4<885::aid-cncr2820220427>3.0.co;2-t.
9
[Vitality evaluation of malignant melanoma metastases following endolymphatic radionuclide therapy using the Falck-Hillarp method].[使用法尔克-希拉尔普方法对放射性核素内淋巴治疗后恶性黑色素瘤转移灶的活力评估]
Hautarzt. 1975 Jun;26(6):317-20.
10
[Clinical results of endolymphatic radionuclide therapy in the treatment of malignant melanoma].
Strahlentherapie. 1974 Jul;148(1):1-15.